These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37886367)

  • 1. Community-based treatment of cutaneous leishmaniasis using cryotherapy and miltefosine in Southwest Ethiopia: the way forward?
    van Henten S; Pareyn M; Tadesse D; Kassa M; Techane M; Kinfe E; Girma N; Demeke D; Mesay M; Kassa M; Temesgen R; Shewangizaw M; Massebo F; van Griensven J; Wegayehu T; Merdekios B
    Front Med (Lausanne); 2023; 10():1196063. PubMed ID: 37886367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for American cutaneous and mucocutaneous leishmaniasis.
    Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.
    van Griensven J; Gadisa E; Aseffa A; Hailu A; Beshah AM; Diro E
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004495. PubMed ID: 26938448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
    van Henten S; Tesfaye AB; Abdela SG; Tilahun F; Fikre H; Buyze J; Kassa M; Cnops L; Pareyn M; Mohammed R; Vogt F; Diro E; van Griensven J
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009460. PubMed ID: 34048461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.
    Fikre H; Mohammed R; Atinafu S; van Griensven J; Diro E
    Trop Med Int Health; 2017 Oct; 22(10):1293-1301. PubMed ID: 28712122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis.
    Mosleh IM; Geith E; Natsheh L; Schönian G; Abotteen N; Kharabsheh S
    J Am Acad Dermatol; 2008 Apr; 58(4):617-24. PubMed ID: 18249466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model.
    Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    J Pharm Pharmacol; 2016 Jul; 68(7):862-72. PubMed ID: 27230300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
    Kämink S; Masih B; Ali N; Ullah A; Khan SJ; Ashraf S; Pylypenko T; Grobusch MP; Fernhout J; den Boer M; Ritmeijer K
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008988. PubMed ID: 33507944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
    Machado PRL; Prates FVO; Boaventura V; Lago T; Guimarães LH; Schriefer A; Corte TWF; Penna G; Barral A; Barral-Netto M; Carvalho EM
    Clin Infect Dis; 2021 Oct; 73(7):e2465-e2469. PubMed ID: 32894278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.
    Parvizi MM; Handjani F; Moein M; Hatam G; Nimrouzi M; Hassanzadeh J; Hamidizadeh N; Khorrami HR; Zarshenas MM
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005957. PubMed ID: 28981503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
    Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of miltefosine in cutaneous leishmaniasis: An open label, non-comparative study from Balochistan.
    Tahir M; Bashir U; Hafeez J; Ghafoor R
    Pak J Med Sci; 2019; 35(2):495-499. PubMed ID: 31086539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for Old World cutaneous leishmaniasis.
    Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
    Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
    J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous leishmaniasis. Diagnosis and therapy in northern Afghanistan].
    Dieterle R; Pillekamp H
    Hautarzt; 2014 Feb; 65(2):125-9. PubMed ID: 24337239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
    Sridharan K; Sivaramakrishnan G
    Acta Trop; 2021 Aug; 220():105944. PubMed ID: 33957088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice.
    Ribeiro JBP; Miranda-Vilela AL; Graziani D; Gomes MRA; Amorim AAS; Garcia RD; de Souza Filho J; Tedesco AC; Primo FL; Moreira JR; Lima AV; Sampaio RNR
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():282-290. PubMed ID: 26306406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
    Tayyebi M; Darchini-Maragheh E; Layegh P; Kiafar B; Goyonlo VM
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009241. PubMed ID: 33739976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.
    Mendes L; Guerra JO; Costa B; Silva ASD; Guerra MDGB; Ortiz J; Doria SS; Silva GVD; de Jesus DV; Barral-Netto M; Penna G; Carvalho EM; Machado PRL
    Int J Infect Dis; 2021 Feb; 103():358-363. PubMed ID: 33253864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.